Placebo-Controlled Therapeutic Trial for the Prevention of Lymphedema

Stopped early · Not applicable · Has a placebo group

Conditions studied: Lymphedema, Unspecified Adult Solid Tumor, Protocol Specific

In brief

This randomized clinical trial studies an investigational drug in preventing lymphedema in patients at high risk after undergoing axillary lymph node dissection. The study drug may prevent lymphedema in patients undergoing axillary lymph node dissection.

Key facts

Study ID

NCT01893879

Run by

Stanford University

People needed

14

Starts

2014-04-01

Expected to finish

2015-04-01

Last updated by the study team

2017-05-18

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Axillary lymph node dissection within the preceding 12 months

You may not qualify if…

• Patients with active cancer
• Patients with lymphedema
• Infection or bleeding tendency
• Patients with medical contraindications to nonsteroidal anti-inflammatory drugs (NSAIDs), including history of allergies, know gastrointestinal intolerance
• Other serious systemic illness (e.g., renal failure, hepatic dysfunction, congestive heart failure, neurological or psychological impairment) that would impair the patients' ability to participate
• Persons not competent to consent
• Patients on aspirin therapy
• Minors (< 18 years of age)
• Pregnant and/or lactating women
• Males

Where it is running

• Stanford University Hospitals and Clinics — Stanford, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.